Fig. 3
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13063-015-0891-y/MediaObjects/13063_2015_891_Fig3_HTML.gif)
10-year outcomes according to induction regimen. a Freedom from acute rejection. b Death-censored graft survival. c Patient survival. d All-cause graft survival. Basi, basiliximab; rATG, rabbit antithymocyte globulin
10-year outcomes according to induction regimen. a Freedom from acute rejection. b Death-censored graft survival. c Patient survival. d All-cause graft survival. Basi, basiliximab; rATG, rabbit antithymocyte globulin